Abstract: Provided are a 3Clpro protease inhibitor, a pharmaceutical composition containing the compound of formula (I), and a method for treating coronavirus by using the compound.

Abstract: A pyrrole amide compound, a pharmaceutical composition thereof and use thereof. The compound or the pharmaceutical composition can be used as a mineralocorticoid receptor antagonist.

Abstract: A phenyl-substituted dihydronaphthyridine compound and use thereof, and further relates to a pharmaceutical composition including the compound. According to the present invention, the compound or the pharmaceutical composition can be used as a mineralocorticoid receptor antagonist.

Abstract: A solid-state disk read/write apparatus includes a solid-state disk assembly (400) and a read/write console (100). The solid-state disk assembly (400) includes a solid-state disk main body (6) and an adapter module (5). The adapter module (5) includes a M.2 connector (52) and a USB connector (53). The solid-state disk main body (6) is electrically connected onto the M.2 connector (52). The read/write console (100) includes a circuit board (2) having a USB engagement connector (21) and a control chip (7) electrically arranged thereon. The solid-state disk assembly (400) uses the USB connector (53) to electrically connect onto the USB engagement connector (21), allowing the solid-state disk main body (6) to electrically connect to the read/write console (100) via the adapter module (5) and the control chip (7). Accordingly, the effects of reducing purchase cost, distributing heat sources and preventing re-insertion of the solid-state disk main body can be achieved.

Abstract: The present invention discloses a ?-polylysine hydrogel and the preparation method and application of the as-described ?-polylysine hydrogel. The polylysine hydrogel is non-toxic to a recipient, and has biodegradability and biocompatibility. The wound tissue healing material prepared by the present invention can be used in wound tissue adhesion in an efficient, stable, safe manner.

Abstract: A hydrogel based on a cross-linked ?-polyglutamic acid and ?-polylysine polymer is obtained by cross-linking of ?-polyglutamic acid with ?-polylysine, and it is a polymer having the following constitutional unit, wherein, m is a natural number of 15 to 45, n is a natural number of 3900 to 17000, and x is a natural number of 5 to 40. It also discloses a preparation method of as-described hydrogel and its application in preparation as a medical wound dressing.

Abstract: The present invention discloses a ?-polylysine hydrogel and the preparation method and application of the as-described ?-polylysine hydrogel. The polylysine hydrogel is non-toxic to a recipient, and has biodegradability and biocompatibility. The wound tissue healing material prepared by the present invention can be used in wound tissue adhesion in an efficient, stable, safe manner.

Abstract: A packaging structure for a container. The packaging structure includes a main frame including a first portion, a second portion and a connecting plate connecting the first and second portions, and a plurality of separators inserted in first and second grooves defined at the first and second portions respectively. The glass substrate is sealed in a loading slot formed by the separators.

Abstract: A packaging structure for a container. The packaging structure comprises a main frame including a first portion, a second portion and a connecting plate connecting the first and second portions, and a plurality of separators inserted in first and second grooves defined at the first and second portions respectively. The glass substrate is sealed in a loading slot formed by the separators.